Commission Implementing Decision (EU) 2020/27 of 13 January 2020 postponing the expiry date of approval of propiconazole for use in biocidal products of product-type 8
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
154/2020 In force in the EEA
Yes Legal documents
Commission Implementing Decision (EU) 2020/27 of 13 January 2020 postponing the expiry date of approval of propiconazole for use in biocidal products of product-type 8
Framkvæmdarákvörðun framkvæmdastjórnarinnar (ESB) 2020/27 frá 13. janúar 2020 um frestun að því er varðar lokadag samþykkis fyrir própíkónasóli til notkunar í sæfivörur í vöruflokki 8
Durchführungsbeschluss (EU) 2020/27 der Kommission vom 13. Januar 2020 zur Verschiebung des Ablaufdatums der Genehmigung von Propiconazol zur Verwendung in Biozidprodukten der Produktart 8
Kommisjonens gjennomføringsbeslutning (EU) 2020/27 av 13. januar 2020 om utsettelse av utløpsdatoen for godkjenningen av propikonazol til bruk i biocidprodukter av type 8
History
24.10.2020
Adopted JCD confirmed entry into force date
24.10.2020
Compliance date in the EEA
23.10.2020
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
08.07.2020
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
13.01.2020
Adoption date in the EU
03.02.2020
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.